Skip to main content icon/video/no-internet

Risk-Benefit Perceptions of Nanotechnology

Data to date indicate that awareness of nanotechnologies among various publics remains low, suggesting that perceptions thereof are based on heuristics derived from earlier experiences. Trust, or lack thereof, in governance institutions and actors is a key factor in this regard. Technological proponents also draw on their understandings of history, including their assessment of public responses to previous technologies. They may see a very different risk-benefit balance than the general public, including the risk of public rejection. Regulatory agencies have yet another lens, and may view emerging technologies partly in terms of threats to their capacity, and opportunities to advance institutional priorities. In summary, various stakeholders are likely to perceive the risk-benefit equation for nanoscale technologies differently.

In terms of public opinion, a limited amount of research has been published so far, mostly assessing attitudes in the Eurpean Union and the United States. Generally, publics on both sides of the Atlantic believe that the benefits of nanoscale technologies will outweigh their risks, although there are some variations between studies. Participants consistently report a low level of awareness of nanotechnologies, and score poorly on factual knowledge tests. Scholars theorize that under such conditions, citizens apply heuristics, or shortcuts, derived from prior experience in order to make judgments. To the degree that this surmise is correct, current opinions toward nanoscale technologies primarily reflect existing attitudes toward technology in general, and the perceived track record of relevant authorities. Thus, public sentiment could shift dramatically in response to either a crisis or a breakthrough, particularly if the event attracted substantial media attention.

The available evidence also indicates that applications matter. Potential technological solutions to recognized societal problems, such as alternative electricity generation, tend to find approval. In such cases, the public benefits are clear, and citizens might well be willing to accept a reasonable level of risk. Applications fraught with moral ambiguity, such as the use of nanotechnologies to create “enhanced” humans, receive less automatic support, and engender more concern. Food is another example: participants in one study rated nanotechnology in food packaging as less problematic than nanoparticles in food for consumption. At this time, public perceptions toward nanotechnologies manifest a combination of application-specific risk/benefit calculation and the adaptation of existing value frameworks to novel hypothetical scenarios. The situation may change as public awareness grows, and the direction of that shift may depend primarily on future “watershed” events.

Differing Perspectives

Businesses producing or employing nanoscale technologies may have a different perspective. Their stakes in the overall game are more immediate, and innovation at the nanoscale requires specific technical knowledge. At the same time, firms of different sizes in various industries may well vary in their perceptions of and attitudes toward risk/benefit trade-offs at the nanoscale. The “Nano Risk Framework” put forward jointly by Environmental Defense (ED), a prominent U.S. environmental nongovernmental organization (NGO), and DuPont, articulates one possible vision, but is not necessarily representative of either the business or the NGO communities.

Approaches like the ED/DuPont framework require companies to make explicit risk/benefit decisions during the course of product development. A thorough evaluation will consider possible effects on workers, ecosystems, and the general public, all of which could have financial consequences for the producer. Conducting such analyses is probably easier for large firms such as DuPont. They have not only the necessary financial resources and expertise, but also the freedom to discontinue development of a particular product without undue impact on the company as a whole, since it has hundreds of others. For smaller entities, particularly startups that depend on a single product or set of technologies, the situation may be more constrained. While they still have latitude with respect some of the details of product design, the go/no-go product decision that is central to the ED/DuPont may not be a realistic option, because “no go” would mean closing the company's doors.

...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles

Sage Recommends

We found other relevant content for you on other Sage platforms.

Loading